Commercial law firm GSK Stockmann successfully advised Pembroke Real Estate on the acquisition of a high-profile development site located on Alramstrasse in Munich’s Sendling district.
The highly complex and time-sensitive transaction involved not only the conclusion of a share and asset deal, but also numerous accompanying agreements and negotiations with multiple parties.
The acquisition marks Pembroke Real Estate’s first foray into the German real estate market. The international real estate firm has already acquired multiple high-end commercial properties in Munich and Hamburg.
An experienced GSK Stockmann team led by partners Volker Hofstetter (Real Estate, Frankfurt) and Marcel Vietor (Corporate, Munich) provided Pembroke Real Estate with comprehensive legal advice to ensure a smooth transaction process.
The successful completion of this complex transaction in such a short timeframe is a testament to the firm’s 360-degree advisory approach, which creates added value for its clients through interdisciplinary and innovative solutions and an in-depth understanding of the legal and economic requirements for these kinds of transactions, even during challenging market phases.
Advisers of Pembroke Real Estate at GSK Stockmann:
Volker Hofstetter (lead, Partner, Real Estate), Dr Marcel Vietor (lead, Partner, Corporate); Andreas Dimmling (Partner, Insolvency & Restructuring); Dr Alma Franke (Partner, Finance); Dr Maximilian Schilling (Partner, Construction Law); Dr Mark Butt (Partner, Public & Planning Law); Dr Timo Bernau (Partner, Regulatory); Jan Kramer (Local Partner, Construction Law); Dr Katharina Odermatt (Local Partner, Real Estate); Felix Bergfort (Local Partner, Real Estate); Dr Mechthild Maria Siebke (Local Partner, Finance); Dominik Berka (Local Partner, Tax); Dr Uta Birk, David Hansen, Claudia Maria Laszuk, Karolin Streser (Associates, Real Estate); Andrea Nowak (Associate, Corporate); Marcel Buss (Associate, Finance); Iryna Stefak (Associate, Construction Law); Leonie Lindenbuß (Associate, Public & Planning Law); Dr Martin Freytag and Nicole Habersetzer (Associates, Regulatory).
